Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Incidental Detection of Pleomorphic Sarcoma on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer

Mathew, Boon MD*; Agrawal, Archi DNB*; Purandare, Nilendu C. DNB*; Ramadwar, Mukta MD; Menon, Santosh MD; Bakshi, Ganesh MCh; Joshi, Amit DM§; Puranik, Ameya DNB*; Shah, Sneha DNB*; Rangarajan, Venkatesh DNB*

doi: 10.1097/RLU.0000000000002760
Interesting Image: PDF Only

68Ga prostate-specific membrane antigen (PSMA) PET/CT is used in the staging, evaluation of biochemical recurrence, and response assessment of patients with prostate cancer. In addition to the PSMA-expressing prostate cancer cells, Ga-PSMA binds to the neovasculaature of various other solid tumors and benign lesions. We report a case of a 72-year-old man with recently diagnosed adenocarcinoma of prostate, incidentally found to have pleomorphic sarcoma on the staging 68Ga-PSMA PET/CT.

From the Departments of *Nuclear Medicine and Molecular Imaging


Surgical Urology

§Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400012, India.

Received for publication June 3, 2019; revision accepted July 2, 2019.

Conflicts of interest and sources of funding: none declared.

Correspondence to: Archi Agrawal, DNB, Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Parel, Mumbai 400012, India. E-mail:

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.